New Guidelines for Managing Immunotherapy-Related Adverse Events

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…

Feb 19^th • 13 mins listen

IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23^rd • 13 mins listen

Experiences With CAR T-Cell Therapy

Kathleen Wiley, RN, MSN, AOCNS®, oncology clinical specialist at ONS, sits down with Megan Harvey, MSN, RN, clinical nurse at the Hospital of the University of Pennsylvania, to discuss Harvey's experience with CAR T-cell therapy. Find out more about this immunotherapy treatment in ca…

Oct 24^th • 14 mins listen